167 related articles for article (PubMed ID: 27197304)
21. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
22. Autophagy in pancreatic cancer: an emerging mechanism of cell death.
Mujumdar N; Saluja AK
Autophagy; 2010 Oct; 6(7):997-8. PubMed ID: 20818166
[TBL] [Abstract][Full Text] [Related]
23. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
Beglyarova N; Banina E; Zhou Y; Mukhamadeeva R; Andrianov G; Bobrov E; Lysenko E; Skobeleva N; Gabitova L; Restifo D; Pressman M; Serebriiskii IG; Hoffman JP; Paz K; Behrens D; Khazak V; Jablonski SA; Golemis EA; Weiner LM; Astsaturov I
Clin Cancer Res; 2016 Dec; 22(24):6153-6163. PubMed ID: 27384421
[TBL] [Abstract][Full Text] [Related]
24. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
25. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
26. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG
Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170
[TBL] [Abstract][Full Text] [Related]
27. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
[TBL] [Abstract][Full Text] [Related]
28. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
29. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
30. Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer.
Uriostegui-Arcos M; Aguayo-Ortiz R; Valencia-Morales MDP; Melchy-Pérez E; Rosenstein Y; Dominguez L; Zurita M
Open Biol; 2020 Jun; 10(6):200050. PubMed ID: 32543350
[TBL] [Abstract][Full Text] [Related]
31. Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure.
Leuenroth SJ; Crews CM
Cancer Res; 2008 Jul; 68(13):5257-66. PubMed ID: 18593926
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
33. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.
Johnson SM; Wang X; Evers BM
J Surg Res; 2011 Jun; 168(2):197-205. PubMed ID: 19922946
[TBL] [Abstract][Full Text] [Related]
34. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
35. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells.
Chen YW; Lin GJ; Chuang YP; Chia WT; Hueng DY; Lin CK; Nieh S; Sytwu HK
Anticancer Drugs; 2010 Jun; 21(5):502-13. PubMed ID: 20154595
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
37. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
38. A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II.
Moreland RJ; Tirode F; Yan Q; Conaway JW; Egly JM; Conaway RC
J Biol Chem; 1999 Aug; 274(32):22127-30. PubMed ID: 10428772
[TBL] [Abstract][Full Text] [Related]
39. A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer.
Tian Q; Zhang P; Wang Y; Si Y; Yin D; Weber CR; Fishel ML; Pollok KE; Qiu B; Xiao F; Chong AS
Elife; 2023 Oct; 12():. PubMed ID: 37877568
[TBL] [Abstract][Full Text] [Related]
40. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
